Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Dendreon: Q1 Earnings Preview
Seeking Alpha
Mon, 04/25/11 - 05:35 pm
Tags:
earnings, Dendreon
Dendreon's Price Run May Be in Anticipation of Stronger Earnings
Seeking Alpha
Wed, 04/20/11 - 09:54 am
Tags:
Dendreon, Provenge, prostate cancer
Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
Seeking Alpha
Mon, 04/11/11 - 02:29 pm
Tags:
hepatitis C, Vertex Pharmaceuticals, Telaprevir, Dendreon, Forest Labs, Orexigen
Why Provenge Could Be a $10 Billion Drug for Dendreon
Seeking Alpha
Mon, 04/11/11 - 11:44 am
Tags:
Provenge, prostate cancer, Dendreon, vaccines
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Seeking Alpha
Sat, 04/9/11 - 11:02 am
Tags:
Prolor, Lexicon Pharmaceuticals, Dendreon, Human Genome Sciences, Targacept, Sequenom, Cadence Pharmaceuticals, Savient, ONYX Pharmaceuticals, Amylin, Emergent BioSolutions, XenoPort, Spectrum Pharmaceuticals, Incyte, Amgen
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 04/4/11 - 11:06 pm
Tags:
Gilead Sciences, Exelixis, Amgen, Dendreon, Immunogen, Maxygen, MannKind, PDL Biopharma, Celgene, Geron, Vertex Pharmaceuticals, Arena Pharmaceuticals, Human Genome Sciences, Orexigen, Biogen Idec
Dendreon Faces Internet-Fueled Shareholder Uprising
Motley Fool
Sun, 04/3/11 - 09:28 am
Tags:
shareholders, Dendreon
Dendreon Remains Neutral
Yahoo/Zacks
Sat, 04/2/11 - 10:13 am
Tags:
Dendreon
Biotech Fever Spreads
Forbes
Thu, 03/31/11 - 12:30 pm
Tags:
biotech, Cephalon, Dendreon, Celgene, Human Genome Sciences
Medicare to pay for $93,000 prostate cancer drug Provenge
Yahoo/AP
Thu, 03/31/11 - 09:58 am
Tags:
Medicare, prostate cancer, Dendreon, Provenge
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Minyanville
Wed, 03/30/11 - 11:24 am
Tags:
Yervoy, Provenge, Dendreon, Bristol-Myers Squibb, melanoma, prostate cancer
CMS Draft Guidance on Dendreon's Provenge Could Be Imminent
Seeking Alpha
Wed, 03/30/11 - 09:41 am
Tags:
Dendreon, Provenge, prostate cancer, vaccines, CMS
Amarin Example Shows Common Sense Is Crucial in Navigating Biotech Sector Volatility
Seeking Alpha
Wed, 03/23/11 - 10:33 am
Tags:
Amarin, BioDelivery Sciences, Dendreon, Human Genome Sciences, MannKind, Titan, Vanda
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
Tags:
ASCO, Medivation, Exelixis, Dendreon, Bristol-Myers Squibb, Roche, Curis, Celgene, Sanofi, Ariad Pharmaceuticals, Merck, Incyte, Novartis, YM BioSciences, Pfizer, Aveo Pharmaceutical, ONYX Pharmaceuticals, Amgen, Synta, Vical, Oxigene, Cell Therapeutics, Oncothyreon
Dendreon's Golden Age Is Still in Its Infancy
Seeking Alpha
Mon, 03/14/11 - 10:20 am
Tags:
Dendreon
Copying Dendreon
Minyanville
Sat, 03/12/11 - 01:16 pm
Tags:
Dendreon
Dendreon wins FDA nod on production increase
Fierce Pharma
Fri, 03/11/11 - 09:41 am
Tags:
FDA, Dendreon, Provenge, vaccines, prostate cancer
When Will Dendreon Make Money?
Motley Fool
Thu, 03/3/11 - 07:57 am
Tags:
Dendreon, vaccines, prostate cancer, Provenge
Biotech Calendar: Key Dates for March
TheStreet.com
Wed, 03/2/11 - 11:59 am
Tags:
Human Genome Sciences, Dendreon, Cell Therapeutics, AP Pharma, Bristol-Myers Squibb, Celgene, Corcept Therapeutics, Achillion
Key Questions For Dendreon
Forbes
Wed, 03/2/11 - 10:32 am
Tags:
Dendreon, Provenge, vaccines, prostate cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.